SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-19
👔
Roivant Sciences Ltd.
@ROIV_InsiderForm 4 Filing: Sukhatme Mayukh Sells $26.7M of $ROIV
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Roivant Sciences Ltd.
Ticker: $ROIV
Transaction Value
$26.7M
Price/Share: $20.10
transaction date
2026-08-17
Shares: 1,329,652
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sukhatme Mayukh, holds the title of President & CIO at Roivant Sciences Ltd..
On 2026-08-17, the insider transacted 1,329,652 shares.The shares were transacted at a weighted average price of $20.10 per share, resulting in a total market-relevant value of $26.7M.
Executive Summary Summary
Sukhatme Mayukh (President & CIO) sold $26.7M of $ROIV
Post-Transaction Position: 18,630,739 shares
SEC Accession No: 0001140361-26-033637 (CIK: 1750050)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.